AILERON THERAPEUTICS
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.
AILERON THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2005-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aileronrx.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 995 0900
Email Addresses:
[email protected]
Total Funding:
218.21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Secondary - Aileron Therapeutics
Acorn Bioventures
Acorn Bioventures investment in Post-IPO Secondary - Aileron Therapeutics
Grand Oaks Capital
Grand Oaks Capital investment in Post-IPO Secondary - Aileron Therapeutics
Satter Investment Management
Satter Investment Management investment in Post-IPO Secondary - Aileron Therapeutics
Maven Investment Partners US
Maven Investment Partners US investment in Post-IPO Secondary - Aileron Therapeutics
BVF Partners
BVF Partners investment in Post-IPO Secondary - Aileron Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series E - Aileron Therapeutics
Excel Venture Management
Excel Venture Management investment in Series E - Aileron Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Series E - Aileron Therapeutics
Lilly Ventures
Lilly Ventures investment in Series E - Aileron Therapeutics
Key Employee Changes
Official Site Inspections
http://www.aileronrx.com
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
